specialised pro-resolving mediator |
|
CHEBI:140399 |
|
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
|
Outgoing
|
specialised pro-resolving mediator
(CHEBI:140399)
is a
anti-inflammatory agent
(CHEBI:67079)
specialised pro-resolving mediator
(CHEBI:140399)
is a
biological role
(CHEBI:24432)
specialised pro-resolving mediator
(CHEBI:140399)
is a
signalling molecule
(CHEBI:62488)
|
|
Incoming
|
(10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoic acid
(CHEBI:140265)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
(CHEBI:138248)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:138249)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(7S,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid
(CHEBI:140193)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid
(CHEBI:140271)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(8S)-cystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid
(CHEBI:140270)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(8S)-glutathionyl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid
(CHEBI:140268)
has role
specialised pro-resolving mediator
(CHEBI:140399)
(8S)-glycinylcystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid
(CHEBI:140269)
has role
specialised pro-resolving mediator
(CHEBI:140399)
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140264)
has role
specialised pro-resolving mediator
(CHEBI:140399)
16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140262)
has role
specialised pro-resolving mediator
(CHEBI:140399)
16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
(CHEBI:140263)
has role
specialised pro-resolving mediator
(CHEBI:140399)
16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoic acid
(CHEBI:140266)
has role
specialised pro-resolving mediator
(CHEBI:140399)
22-hydroxyprotectin D1
(CHEBI:140243)
has role
specialised pro-resolving mediator
(CHEBI:140399)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
(CHEBI:140272)
has role
specialised pro-resolving mediator
(CHEBI:140399)
7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid
(CHEBI:140273)
has role
specialised pro-resolving mediator
(CHEBI:140399)
aspirin-triggered protectin D1
(CHEBI:140202)
has role
specialised pro-resolving mediator
(CHEBI:140399)
lipoxin
(CHEBI:6497)
has role
specialised pro-resolving mediator
(CHEBI:140399)
protectin D1
(CHEBI:138655)
has role
specialised pro-resolving mediator
(CHEBI:140399)
resolvin
(CHEBI:132120)
has role
specialised pro-resolving mediator
(CHEBI:140399)
|
specialised pro-resolving mediators
|
ChEBI
|
specialised proresolving mediator
|
ChEBI
|
specialised proresolving mediators
|
ChEBI
|
specialized pro-resolving mediator
|
ChEBI
|
specialized pro-resolving mediators
|
ChEBI
|
specialized proresolving mediator
|
ChEBI
|
specialized proresolving mediators
|
ChEBI
|
SPM
|
ChEBI
|
SPMs
|
ChEBI
|
|